Runlan Huo
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 4
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Menghuan Li (2 shared papers)Ke Li (2 shared papers)Zhong Luo (2 shared papers)Kaiyong Cai (2 shared papers)Linawati Sutrisno (1 shared paper)Chencheng Xue (1 shared paper)Lu Lu (1 shared paper)Jun Zhou (1 shared paper)
- Journals
- Drug Metabolism and Disposition (3 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)ACS Nano (1 paper)Journal of Pharmaceutical Sciences (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Runlan Huo
8 papers receiving 474 citations
Runlan Huo's Hit Papers
Peers
Comparison fields: 5 of 61
- Biomaterials 167
- Biomedical Engineering 387
- Materials Chemistry 223
- Cancer Research 31
- Molecular Biology 135
Countries citing papers authored by Runlan Huo
This map shows the geographic impact of Runlan Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runlan Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runlan Huo more than expected).
Fields of papers citing papers by Runlan Huo
This network shows the impact of papers produced by Runlan Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runlan Huo. The network helps show where Runlan Huo may publish in the future.
Co-authors
The 25 scholars most cited alongside Runlan Huo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Engineering of a Nanosized Biocatalyst for Combined Tumor Starvation and Low-Temperature Photothermal Therapy Hit paper breakdown → | 2018 | 393 |
| 2 | 2017 | 52 | |
| 3 | 2024 | 12 | |
| 4 | 2023 | 11 | |
| 5 | 2024 | 5 | |
| 6 | 2012 | 5 | |
| 7 | 2025 | 2 | |
| 8 | 2025 | 1 | |
| 9 | 2025 | 1 | |
| 10 | 1998 | 0 |
About Runlan Huo
Runlan Huo is a scholar working on Oncology, Pharmacology, Rheumatology, Molecular Biology and Clinical Biochemistry, having authored 10 papers that have together received 482 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Folate and B Vitamins Research (3 papers), Metabolism and Genetic Disorders (2 papers), Receptor Mechanisms and Signaling (2 papers), Nanoplatforms for cancer theranostics (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Biomaterials (167 citations), Biomedical Engineering (387 citations), Materials Chemistry (223 citations), Cancer Research (31 citations) and Molecular Biology (135 citations). Runlan Huo has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Menghuan Li, Ke Li, Zhong Luo, Kaiyong Cai, Linawati Sutrisno, Chencheng Xue, Lu Lu, Jun Zhou, Yanhua Hou and Qiufang Chen. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, ACS Nano, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.